A Novel Posttraumatic Stress Disorder Treatment for Veterans with Moral Injury
A Novel Posttraumatic Stress Disorder Treatment for Veterans with Moral Injury
批准号:
10705560
负责人:
Shira Maguen
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-12-31
关键词:
AddressAftercareAlcohol abuseAngerAreaAttentionBehaviorBeliefCaringCessation of lifeClinical TreatmentClinical assessmentsCognitionCognitiveCommunitiesComplexConflict (Psychology)Control GroupsDevelopmentDiagnosisEducationEvaluationExposure toFamilyFeelingFundingGenerationsGoalsGrantGuiltHealthcare SystemsImpairmentIndividualInterventionLearningMeasuresMediatorMental HealthModelingMoral injuryMoralsOutcomeParticipantPatientsPerformancePhysiologyPost-Traumatic Stress DisordersPsychotherapyQuality of lifeRandomizedRandomized, Controlled TrialsRehabilitation therapyRiskSample SizeSan FranciscoSelf-Injurious BehaviorSeveritiesShameSigns and SymptomsSiteSocial isolationSpiritualitySuicideSymptomsTarget PopulationsTestingThinkingTimeTraumaVeteransVeterans Health AdministrationVisitWaiting ListsWarWorkactive controlcare systemscombatcombat veterancostdesigndiagnostic criteriaefficacy testingefficacy trialevidence baseexpectationexperiencefollow up assessmentfollow-upforgivenessfunctional disabilityfunctional gainfunctional improvementimprovednovelpilot trialpreventprimary outcomepsychiatric symptompsychological distresspsychological traumapsychosocialresponsesecondary outcomeskillsstemsuicidalsuicide ratesymptomatic improvementtreatment group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Post-traumatic stress disorder (PTSD) is now the most common mental health diagnosis among the youngest
generation of Veterans receiving treatment from the Veterans Health Administration (VHA), necessitating the
need for diverse types of targeted care. Although there are two evidence-based psychotherapies (EBP) for
PTSD, the vast majority of combat Veterans who receive these treatments still meet diagnostic criteria for
PTSD and their functioning continues to be impacted. Furthermore, Veterans that have experienced trauma
related to killing have high rates of suicide and more severe PTSD symptoms. Although there have been few
studies examining predictors of poor outcomes in EBPs, one area that has recently begun to receive growing
attention is moral injury. A recent study found that PTSD and moral injury were distinct constructs with unique
signs and symptoms, and preliminary evidence indicates that the feelings of guilt and anger that characterize
moral injury associated with trauma such as killing in war may contribute to worsening symptoms over the
course of existing treatments. Although PTSD may be one manifestation of psychological trauma related to
killing, conceptualization of the impact of killing requires a broader framework. The emerging concept of moral
injury offers an alternative context to better understand the many possible outcomes of exposure to killing. For
these reasons, the development of targeted moral injury interventions is critical. We designed and received VA
funding to conduct a pilot randomized controlled trial (RCT) of the Impact of Killing (IOK) treatment, which can
be seamlessly added as a standalone treatment following existing EBPs for PTSD. IOK focuses on key themes
including physiology of killing responses, moral injury, self-forgiveness, and improved post-deployment
reintegration. The treatment was designed to fit well into already existing systems of care and has been shown
to improve functioning, PTSD symptoms, and general psychiatric symptoms following EBP. Whereas the IOK
RCT pilot was initially conducted at the San Francisco VA Healthcare System, our goal is to conduct a fully-
powered, multi-site efficacy trial at two regionally-diverse sites with a larger sample size and active control
condition. Consequently, the objective of this project is to test the efficacy of an individual treatment for PTSD
stemming from moral injury called IOK, compared to a present-centered therapy (PCT) control condition, and
to determine the rehabilitative utility of IOK for Veterans seeking treatment for PTSD. Our primary outcome is
psychosocial functioning. The target population is Veterans who have initiated or completed Cognitive
Processing Therapy or Prolonged Exposure Therapy, two EBPs for PTSD, and continue to have PTSD
symptoms and moral injury related to killing. Veterans will be randomly assigned to receive either: 1) IOK (10
individual therapy sessions lasting 60-90 minutes) or 2) PCT (sessions of equal duration to IOK). Our first aim
is to test the efficacy of IOK through measures of psychosocial functioning (primary outcome) and PTSD
severity (secondary outcome). Our second aim is to determine whether IOK gains made by Veterans are
durable. Given that moral injury treatment is a new and burgeoning area, we have two exploratory aims that
can help move the field forward. Our first exploratory aim is to conduct post-treatment evaluations with a
subset of the IOK treatment group to better understand how to support continued improvement in functioning
among participants. Our second exploratory aim is to evaluate mediators of functional improvement, such as
self-forgiveness, among Veterans completing IOK. If the aims of this grant are achieved, we will be able to
have a moral injury intervention following EBP that can be seamlessly integrated into existing care for one of
the most commonly occurring mental health problems in Veterans. Furthermore, suicide is a national priority
for VHA, and expanding treatment for PTSD and moral injury has the potential to decrease suicide and
improve functioning in Veterans. Finally, IOK offers skills and ways of understanding warzone experiences that
can be mastered and can continue to be implemented by Veterans over time.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s40501-022-00262-6
发表时间:
2022
期刊:
Current treatment options in psychiatry
影响因子:
--
作者:
[Burkman, Kristine, Gloria, Rebecca, Mehlman, Haley, Maguen, Shira]
通讯作者:
Maguen, Shira
A Novel Posttraumatic Stress Disorder Treatment for Veterans with Moral Injury
-
批准号:10399986
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Shira Maguen
-
依托单位:
Eating Disorder Screening and Diagnostic Tools for the Veteran Healthcare System
-
批准号:10651595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Shira Maguen
-
依托单位:
Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans
-
批准号:9379807
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Shira Maguen
-
依托单位:
Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans
-
批准号:8983263
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Shira Maguen
-
依托单位:
海外基金